Clinical Trial Update: Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing intralesional versus intramuscular Hepatitis B vaccine as immunotherapy for multiple common warts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Zagazig University | Conditions: Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts | Phase 1, Phase 2 | Status: COMPLETED